Latch (LTCH) Competitors $0.12 -0.01 (-7.69%) As of 09/12/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock LTCH vs. DLXY, GDC, NHTC, RAVE, HWH, COSM, DTCK, HYFM, SCNX, and BANLShould you be buying Latch stock or one of its competitors? The main competitors of Latch include Delixy (DLXY), GD Culture Group (GDC), Natural Health Trends (NHTC), Rave Restaurant Group (RAVE), HWH International (HWH), Cosmos Health (COSM), Davis Commodities (DTCK), Hydrofarm Holdings Group (HYFM), Scienture (SCNX), and CBL International (BANL). These companies are all part of the "wholesale" industry. Latch vs. Its Competitors Delixy GD Culture Group Natural Health Trends Rave Restaurant Group HWH International Cosmos Health Davis Commodities Hydrofarm Holdings Group Scienture CBL International Latch (NASDAQ:LTCH) and Delixy (NASDAQ:DLXY) are both small-cap wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends. Is LTCH or DLXY more profitable? Company Net Margins Return on Equity Return on Assets LatchN/A N/A N/A Delixy N/A N/A N/A Do insiders and institutionals hold more shares of LTCH or DLXY? 0.4% of Latch shares are owned by institutional investors. 27.5% of Latch shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor LTCH or DLXY? In the previous week, Delixy had 1 more articles in the media than Latch. MarketBeat recorded 1 mentions for Delixy and 0 mentions for Latch. Delixy's average media sentiment score of 1.89 beat Latch's score of 0.00 indicating that Delixy is being referred to more favorably in the news media. Company Overall Sentiment Latch Neutral Delixy Very Positive Which has better valuation and earnings, LTCH or DLXY? Delixy has lower revenue, but higher earnings than Latch. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLatch$48.39M0.41-$162.34MN/AN/ADelixyN/AN/AN/AN/AN/A SummaryLatch beats Delixy on 3 of the 5 factors compared between the two stocks. Get Latch News Delivered to You Automatically Sign up to receive the latest news and ratings for LTCH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LTCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LTCH vs. The Competition Export to ExcelMetricLatchHardware IndustryAuto SectorNASDAQ ExchangeMarket Cap$19.78M$19.78M$20.19B$10.14BDividend YieldN/AN/A2.65%4.59%P/E RatioN/AN/A17.8025.93Price / Sales0.410.4143.76126.97Price / CashN/AN/A20.9260.44Price / BookN/AN/A2.876.29Net Income-$162.34M-$162.34M$831.18M$270.77M7 Day Performance-25.00%-25.00%12.31%3.88%1 Month Performance-7.69%-7.69%-0.47%4.88%1 Year Performance-75.00%-75.00%12.49%26.01% Latch Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LTCHLatchN/A$0.12-7.7%N/A-73.3%$19.78M$48.39M0.00420Gap DownDLXYDelixyN/A$5.00-5.7%N/AN/A$81.75MN/A0.00N/APositive NewsGDCGD Culture Group0.4029 of 5 stars$3.82-6.1%N/A+47.3%$64.18MN/A-5.1660News CoveragePositive NewsGap UpNHTCNatural Health Trends1.3598 of 5 stars$4.45+1.1%N/A-31.1%$51.22M$42.96M148.38140Positive NewsRAVERave Restaurant Group2.1683 of 5 stars$3.20-3.9%N/A+106.4%$45.47M$12.15M16.8420Positive NewsGap UpHWHHWH International1.5853 of 5 stars$4.72+227.8%N/A+30.9%$30.59M$1.25M0.00N/APositive NewsShort Interest ↓High Trading VolumeCOSMCosmos Health1.9851 of 5 stars$0.79-0.1%N/A-6.3%$23.84M$54.43M-0.77100News CoverageShort Interest ↓DTCKDavis Commodities1.0074 of 5 stars$0.87+18.2%N/A-27.3%$21.38M$132.37M0.0022HYFMHydrofarm Holdings Group1.3619 of 5 stars$4.43-4.5%N/A-52.4%$20.64M$190.29M-0.33840News CoverageSCNXScienture1.1086 of 5 stars$0.98+0.2%N/AN/A$20.28M$140K0.00N/APositive NewsBANLCBL International0.4183 of 5 stars$0.68+2.6%N/A+11.0%$18.56M$592.52M0.0035Short Interest ↑ Related Companies and Tools Related Companies Delixy Alternatives GD Culture Group Alternatives Natural Health Trends Alternatives Rave Restaurant Group Alternatives HWH International Alternatives Cosmos Health Alternatives Davis Commodities Alternatives Hydrofarm Holdings Group Alternatives Scienture Alternatives CBL International Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LTCH) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Latch, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Latch With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.